![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 30, 2005 12:26:50 AM
.....
re Biotronik's AMS
Biotronik's Absorbable Metal Stent (AMS) appears that it might be a breakthrough in stent technology.
The technology for their AMS has been collaborated on heavily by Aachen Resonance, from whom Biophan recently acquired exclusive rights to advanced mri technology for coated stents. Biotronik's AMS is being developed in Europe to eventually be marketed as a coated, drug-eluting stent (DES). Aachen's CEO, Dr. Alexander Reubben and Dr. Bucker, Aachen's renowned mri expert, are now under contract with BIPH to further develop the technology that they licensed to BIPH. At the same time, they are working closely with Biotronik on the drug-eluting AMS.
Something tells me that BIPH has a finger in Biotronik's future AMS pie.
Biotronik/Aachen collaboration link:
http://www.biotronik.com/content/detail.php?id=2685
Biophan / Aachen licensing deal p/r link:
http://www.biophan.com/pr/061605License.html
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM